Luspatercept significantly improved hemoglobin levels in non-transfusion-dependent patients with lower-risk myelodysplastic syndromes, potentially delaying transfusion needs. The study showed a 47.6% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback